Page last updated: 2024-10-22

amifostine anhydrous and Pleuropericarditis

amifostine anhydrous has been researched along with Pleuropericarditis in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Pleuropericarditis: Inflammation of both the PERICARDIUM and the PLEURA.

Research Excerpts

ExcerptRelevanceReference
"Acute pericarditis was detected in all rats receiving radiotherapy."1.72Could Amifostine Prevent Experimental Radiotherapy-Induced Acute Pericarditis? ( Bahat, Z; Caner Karahan, S; Cobanoglu, U; Kalyoncu, Nİ; Ulku, C; Yavuz, MN, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bahat, Z1
Cobanoglu, U1
Ulku, C1
Kalyoncu, Nİ1
Caner Karahan, S1
Yavuz, MN1

Other Studies

1 other study available for amifostine anhydrous and Pleuropericarditis

ArticleYear
Could Amifostine Prevent Experimental Radiotherapy-Induced Acute Pericarditis?
    Asian Pacific journal of cancer prevention : APJCP, 2022, Sep-01, Volume: 23, Issue:9

    Topics: Amifostine; Animals; Antioxidants; Inflammation; Pericarditis; Radiation Injuries; Radiation-Protect

2022